Jon Snodgres, CFO at REPLIGEN CORP (RGEN), sold 63,506 shares at $63.49 ($4.0M) on 2018-11-26, disclosed to the SEC on 2018-11-28.
Open-market sale of $4.0M RGEN by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.49 | 31,753 | $2.0M | 50.0% |
| 2 | $63.49 | 31,753 | $2.0M | 50.0% |
| Total | $63.49 avg | 63,506 | $4.0M | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |